• Hematoxylin and Eosin Staining Kit: Technical Workflow Guide

  2026-05-13

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides ready-to-use solutions for efficient visualization of cellular and tissue morphology in research applications. It addresses the need for reproducible, high-contrast nuclear and cytoplasmic staining in paraffin-embedded, frozen, or cytological samples. This kit is not intended for diagnostic or clinical decision-making and should be used exclusively in research workflows.

• Sumatriptan’s Anti-Inflammatory Actions: Systematic Review I

  2026-05-13

  Ala et al. systematically reviewed evidence demonstrating that sumatriptan, beyond its well-known role in migraine management, possesses significant anti-inflammatory effects through modulation of cytokines, nitric oxide signaling, and neuropeptide release. These findings open new avenues for exploring serotonergic agents in inflammatory disease models and highlight the value of cross-domain pharmacological repositioning.

• Hematoxylin and Eosin Staining Kit: Technical Use and QC Gui

  2026-05-12

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides standardized, ready-to-use solutions for consistent visualization of tissue and cellular morphology in research contexts. It is appropriate for paraffin-embedded and frozen tissue section staining but is not intended for diagnostic or clinical use. Use this kit to support robust histopathological workflows and cellular structure assessment, following best-practice protocols.

• Red Blood Cell Lysis Buffer: Optimizing Erythrocyte Removal

  2026-05-12

  Unlock high-yield, nucleated cell isolation with APExBIO's Red Blood Cell Lysis Buffer, designed for selective erythrocyte clearance in whole blood. Discover advanced protocol refinements, cross-validated troubleshooting tips, and application-driven insights for flow cytometry, nucleic acid, and protein extraction.

• Deep Profiling of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)qu

  2026-05-11

  Explore the advanced scientific rationale and mechanistic depth behind 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as a selective α2-adrenergic receptor agonist. This article uncovers new assay strategies, reveals unique bioinformatics-driven applications, and differentiates its content from existing literature for researchers targeting immune rejection modulation.

• TG003 Cdc2-like kinase inhibitor: Protocols and Splicing Res

  2026-05-11

  TG003 stands out as a potent, selective Cdc2-like kinase inhibitor that empowers precise modulation of alternative splicing and mechanistic cancer research. This guide translates the latest evidence—including platinum resistance breakthroughs—into actionable protocols, troubleshooting insights, and workflow enhancements for advanced splicing modulation and exon-skipping studies.

• Deferoxamine Mesylate: Iron-Chelating Agent for Advanced Ass

  2026-05-10

  Deferoxamine mesylate stands out as a versatile iron-chelating agent, enabling precise modulation of iron-dependent cellular processes and hypoxic signaling. Discover how APExBIO's reagent drives workflow innovation for oxidative stress protection, ferroptosis research, and HIF-1α stabilization across oncology and regenerative medicine.

• X-Gal: Precision Blue-White Colony Screening in Molecular Cl

  2026-05-09

  X-Gal from APExBIO is the trusted standard for high-contrast blue-white colony screening and β-galactosidase reporting, enabling rapid, reproducible detection of recombinant clones. Drawing on recent sensory biology research and validated workflows, this article bridges molecular cloning with innovative applications and offers actionable troubleshooting strategies for consistent results.

• X-Gal in Modern Molecular Cloning: Beyond Blue-White Screeni

  2026-05-09

  Explore the advanced roles of X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) in molecular cloning and β-galactosidase assays. This article delivers a deep-dive into mechanisms, assay design, and new scientific insights for maximizing reliability in recombinant DNA technology.

• HSP70 Modulates TDP-43 Condensation in Poly-PR-Induced Stres

  2026-05-08

  Agnihotri et al. elucidate how C9ORF72 poly-PR dipeptides disrupt TDP-43 nuclear condensation via NEAT1, revealing the pivotal role of HSP70 chaperone activity in maintaining condensate dynamics. These findings provide mechanistic insight into ALS/FTD pathology and inform experimental strategies for chaperone-targeted research.

• Comparative Antibacterial Efficacy of N-Formimidoyl Thienamy

  2026-05-07

  This article examines a pivotal comparative study assessing the antibacterial activity of N-formimidoyl thienamycin (MK0787) against a range of resistant clinical isolates, benchmarking its performance alongside recently developed β-lactam antibiotics, including cefoperazone. The findings inform rational selection and design of in vitro antimicrobial assays and highlight the need for nuanced interpretation of β-lactamase stability and spectrum in translational research.

• Etoposide (VP-16): Precision DNA Damage Induction in Cancer

  2026-05-07

  Etoposide (VP-16) is a potent DNA topoisomerase II inhibitor widely used to induce DNA double-strand breaks and apoptosis in cancer cell models. Its variable cytotoxicity, robust solubility in DMSO, and validated efficacy in both in vitro and in vivo systems make it a benchmark compound for DNA damage assays. This article details its mechanism, application limits, and standardized workflow parameters for research.

• Perospirone Inhibits Vascular Kv1.5 Channels: New Off-Target

  2026-05-06

  This study demonstrates that Perospirone, a second-generation antipsychotic, inhibits voltage-gated Kv1.5 potassium channels in coronary arterial smooth muscle cells—an unrecognized off-target effect. These findings expand our understanding of Perospirone’s pharmacology, highlighting implications for both schizophrenia research and cardiovascular safety assessments.

• ML385: Strategic NRF2 Inhibition for Translational Oncology

  2026-05-06

  Explore how ML385, a selective NRF2 inhibitor from APExBIO, enables translational researchers to dissect oxidative stress, therapeutic resistance, and ferroptosis in cancer and liver disease models. This thought-leadership article bridges mechanistic insight, protocol optimization, and strategic guidance for impactful lab-to-clinic research.

• iRhom2 Regulates Olfactory Receptor Expression and Sensory A

  2026-05-05

  Azzopardi et al. (2024) reveal that iRhom2 is uniquely expressed in olfactory sensory neurons and orchestrates odorant receptor gene regulation and activity-dependent adaptation. This work defines a feedback mechanism by which odor exposure modulates iRhom2 and, consequently, olfactory receptor expression, advancing understanding of GPCR-mediated signaling in sensory systems.

16381 records 3/1093 page Previous Next 12345 下5页 Last page